Concise Review: Guidance in Developing Commercializable Autologous/Patient‐Specific Cell Therapy Manufacturing. (7th October 2013)
- Record Type:
- Journal Article
- Title:
- Concise Review: Guidance in Developing Commercializable Autologous/Patient‐Specific Cell Therapy Manufacturing. (7th October 2013)
- Main Title:
- Concise Review: Guidance in Developing Commercializable Autologous/Patient‐Specific Cell Therapy Manufacturing
- Authors:
- Eaker, Shannon
Armant, Myriam
Brandwein, Harvey
Burger, Scott
Campbell, Andrew
Carpenito, Carmine
Clarke, Dominic
Fong, Timothy
Karnieli, Ohad
Niss, Knut
Van't Hof, Wouter
Wagey, Ravenska - Abstract:
- Abstract : In this technical review, members of the International Society for Cell Therapy (ISCT) provide guidance in developing commercializable autologous and patient‐specific manufacturing strategies from the perspective of process development. Guidance is provided to help small academic or biotech researchers determine what questions can be addressed at the bench level in order to make their cell therapy products more feasible for commercial‐scale production. Abstract : Cell therapy is poised to play an enormous role in regenerative medicine. However, little guidance is being made available to academic and industrial entities in the start‐up phase. In this technical review, members of the International Society for Cell Therapy provide guidance in developing commercializable autologous and patient‐specific manufacturing strategies from the perspective of process development. Special emphasis is placed on providing guidance to small academic or biotech researchers as to what simple questions can be addressed or answered at the bench in order to make their cell therapy products more feasible for commercial‐scale production. We discuss the processes that are required for scale‐out at the manufacturing level, and how many questions can be addressed at the bench level. The goal of this review is to provide guidance in the form of topics that can be addressed early in the process of development to better the chances of the product being successful for future commercialization.
- Is Part Of:
- Stem cells translational medicine. Volume 2:Number 11(2013)
- Journal:
- Stem cells translational medicine
- Issue:
- Volume 2:Number 11(2013)
- Issue Display:
- Volume 2, Issue 11 (2013)
- Year:
- 2013
- Volume:
- 2
- Issue:
- 11
- Issue Sort Value:
- 2013-0002-0011-0000
- Page Start:
- 871
- Page End:
- 883
- Publication Date:
- 2013-10-07
- Subjects:
- Cellular therapy -- Stem cells -- Stem cell culture -- Clinical translation
Stem cells -- Periodicals
Regenerative medicine -- Periodicals
Periodicals
616.0277405 - Journal URLs:
- https://academic.oup.com/stcltm ↗
http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/issues/ ↗
http://stemcellstm.alphamedpress.org/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.5966/sctm.2013-0050 ↗
- Languages:
- English
- ISSNs:
- 2157-6564
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2401.xml